Archive for December, 2009

In Memoriam: Peter Csizmadia

Tuesday, December 15th, 2009

I just learnt about a terrible news, that deeply saddened me. Peter Csizmadia, one of the founders of ChemAxon, and the father of Marvin, disappeared on a mountain climbing expedition in China, in October 2009. I learnt about Peter, a few months ago, when I saw his breath taking picture on one of the summits of the world with a ChemAxon memorabilia:
http://picasaweb.google.com/real.csizi/PeterCsizmadia#5409623424222466162

Very brave, and very talented - I thought - when I read about his background at the time. Since I know his brother Csizi, the other founder of ChemAxon, and many other exceptionally talented people at ChemAxon, this did not come as a surprise to me. ChemAxon IS a great team of exceptionally talented and hard working people, conquering even the most difficult peaks.

My sincere condolences to the family, the company, and to science. Loss of Peter is a great tragedy. However, his short life was not in vain, the fruits of his work, like Marvin, make his memory live forever.

posted by Aniko

ARChem 2009.1 is released

Thursday, December 10th, 2009

<meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.08in">2009 has been a year of major progress for ARChem, and the system has hit a number of significant milestones that secured its leading position in the field. We wanted to share a few of our achievements, and to extend our gratitude to many users whose comments have made an impact on the system.</p> <ol> <li> <p align="justify" style="margin-bottom: 0.08in">Chemistry – Several changes to chemical perception algorithms have been implemented. They improve the way target molecules are being addressed, and the way reaction rules are being extracted and clustered from reaction databases. Those improvements have made a small set of manually coded reaction rules obsolete, and have enhanced the system’s capability to deal with some of the challenging aspects of organic synthesis such as chemical interference, stereochemistry and regioselectivity.</p> </li> <li> <p align="justify" style="margin-bottom: 0.08in">Data – As a knowledge-based system, ARChem is highly dependent on the quality and quantity of reactions data encapsulated in commercial databases. We are therefore grateful and proud to have further tightened our relationships with two leaders of the chemical information publishing industry: Elsevier and Symyx. Both CrossFire Beilstein, and Cheminform databases have been fully integrated into the system. Covering a vast spectrum of chemical reactions and offering valuable supporting information through the system.</p> </li> <li> <p align="justify" style="margin-bottom: 0.08in">Breaking up starting materials – The search down a branch of the retrosynthetic tree stops whenever a starting material from the educts database is found. Sometimes it is desirable to break such compounds to even simpler precursors, since they are expensive to purchase, not in stock, etc. The user can now exclude starting materials matching the target molecules, and find synthetic routes to those compounds.</p> </li> <li> <p align="justify" style="margin-bottom: 0.08in">Viewing solutions – The ability to browse through the manifold of generated solutions has been dramatically improved by a synoptic view of reaction steps. The user can see a “preview” of the various solutions by inspecting the list of the next proposed precursors, and jump directly to the associated solutions.</p> </li> <li> <p align="justify" style="margin-bottom: 0.08in">System design – ARChem is now a more complete system which can be used not only as a local installation, but also as an online service. A queueing system, security features, accelerated search times and many other features have upgraded the system performance, accessibility and usability.</p> </li> </ol> <p align="justify" style="margin-bottom: 0.08in">Below is an example for a synthetic route found by ARChem for Maraviroc – an HIV drug that was developed in Pfizer’s labs in Sandwich, UK, and got FDA approval in 2007. ARChem’s solution includes 9 reactions, with 6 steps in the two longest paths. In this case, the retrosynthetic analysis leads all the way back to commercially available starting materials, shown with their corresponding providers and catalog numbers. ARChem supplies a lot more information to complete the experimental details of the synthetic scheme, such as, reaction conditions, bibliographic references, and additional starting materials providers and catalog numbers.</p> <p align="justify" style="margin-bottom: 0.08in"><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg" /></p> <p><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg"> </a><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg"> </a><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg"> </a></p> <div style="text-align: center"><a target="_blank" title="Maraviroc Sol#13 Full Size with ARChem 2009.1" href="http://www.simbiosys.ca/blog/images/maraviroc_solution_13.jpg"><img alt="Maraviroc Sol#13 with ARChem 2009.1" title="Maraviroc Sol#13 with ARChem 2009.1" src="http://www.simbiosys.ca/blog/images/maraviroc_solution_13_thumb.jpg" /></a></div> <div style="text-align: center">Click on the image to see it full size</div> <p align="justify" style="margin-bottom: 0.08in">The above suggested synthetic route has been generated completely automatically with no user intervention. It is a strong demonstration of the huge potential of this concept, and of the accomplishments so far. We look forward to 2010 with plenty of items in the ARChem pipeline, and we are particularly eager to continue the dialogue with our industrial and academic users – a scientific exchange that guarantees that the development process maintains continuous, rigorous and coherent progress.</p> <p align="justify" style="margin-bottom: 0.08in">posted by Orr Ravitz</p> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a>, <a href="http://www.simbiosys.com/blog/category/science/" title="View all posts in Science" rel="category tag">Science</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a> | <a href="http://www.simbiosys.com/blog/2009/12/10/archem-20091-is-released/#respond" title="Comment on ARChem 2009.1 is released">No Comments »</a></p> </div> <div class="post"> <h3 id="post-85"><a href="http://www.simbiosys.com/blog/2009/12/01/ehits-2009-as-a-blind-docking-tool/" rel="bookmark" title="Permanent Link to eHiTS 2009 as a Blind Docking Tool">eHiTS 2009 as a Blind Docking Tool</a></h3> <small>Tuesday, December 1st, 2009</small> <div class="entry"> <p><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">As the molecular docking paradigm solidifies its status as a significant tool for drug discovery, chemists explore additional applications of the methods in ways that sometime stretch the existing algorithms to their limits. Most docking programs, including eHiTS, have not been designed or optimized to perform blind docking. In structure based drug discovery, the user is typically expected to define, at some level of accuracy, the binding pocket in the target of interest. The binding site is determined either based on known binding modes of ligands as found in crystal structures of complexes, or based on an educated hypothesis. There are cases, however, in which assumptions about the possible locations of binding hot spots are difficult or should be avoided altogether. This is the case, for example, when the existence of secondary binding sites is suspected, or when one would like to screen active ligands and other compounds on a range of targets to estimate the possibility for drug side-effects, toxicity, and other types of biological activities.</font></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">The standard eHiTS usage requires a rough definition of the binding pocket. This is done through the clip file. This file should contain at least two sets of coordinates (or two spatial points) that are located in the designated binding pocket. eHiTS then draws a box around those points, expands it to some extent in all directions and places the search grid inside that box. Then, the box is “flooded” with a virtual fluid to detect all the cavities which will define the binding surface. This is a highly automated process, but it still relies on that user-defined clipping. Commonly the native ligand, amino acids from the binding pocket, or a few atoms from either are chosen as a clip file. If eHiTS is run with the -complex option, the native ligand is inferred as the clipping coordinates. However, eHiTS could be used without any clipping. In this case, the entire receptor will be considered for docking. The whole protein will be flooded, and sufficiently deep clefts will be searched on its surface. The final space in which docking will be performed is defined by the interconnected pockets found on the target. The search grid in such scenarios is typically large, and extensive sampling is required. Nevertheless, the computational efficiency of the eHiTS algorithm allows good sampling in reasonable timescales.</font></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">Several eHiTS users expressed specific interest in blind docking in recent months, and therefore we decided to evaluate eHiTS’ performance in this context. We used the set that was used in an earlier blind docking evaluation (</font><a target="_blank" title="Reference 1" href="http://autodock.scripps.edu/resources/science/hetenyi2006b.pdf"><font color="#000080"><u><font face="Liberation Serif, Times New Roman, serif">Hetenyi and van der Spoel, </font></u></font><font color="#000080"><u><font face="Liberation Serif, Times New Roman, serif"><strong>2006 [1]</strong></font></u></font></a><font face="Liberation Serif, Times New Roman, serif">). We focused on the 43 complexes used in the paper and have not attempted to use the apo structures. 3 codes (1B70, 1FIW and 1QIZ) were left out because of uncertainty regarding the exact structure used in the paper for docking. The default accuracy (3) was used throughout the study. The average blind docking time was 9 minutes per receptor for this set.</font></p> <p align="justify" style="margin-bottom: 0.08in"><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif"><strong>Results</strong></font><font face="Liberation Serif, Times New Roman, serif">:</font></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">77.5% of the cases gave at least one conformation under 2 </font><font face="Liberation Serif, Times New Roman, serif">Å in the top 10 poses. In the other cases, one accumulative docking round using poses from the first round as clip files produced successful binding modes in the top 5 poses. The top rank pose is in most cases in the correct binding pocket, offering a good starting point for pose refinement.</font></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">The table <a target="_blank" title="eHiTS 2009.1 blind docking results in table form" href="http://www.simbiosys.ca/blog/2009-11-30-blind_docking_blog_results_table.html">here</a> details the results for the specific codes. The Job# column describes whether the results were obtained with a single blind docking run, or with 2 cycles. The Rank# and RMSD columns indicate the rank of the first pose under 2 Å and its RMSD from the crystallographic conformation. The last two columns indicate the top-rank and closest poses RMSDs.</font></p> <p><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.4 (Unix)" name="GENERATOR" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif">The blind docking of phenol into insulin (1MPJ) is shown in Picture1 below. The crystallographic pose is shown in cyan, and sample poses are shown in “hot spots” detected during docking. Those poses can be used to clip the receptor in accumulative docking runs in which the sampling is finer, and the binding pockets are better modelled. It should be noted that this code generates an unusually big number (5) of hot spots. In most cases in the set we observed three, two and often one hot spot, manifesting the detection of the correct binding pocket.</font></p> <p><img align="middle" title="1MPJ" alt="1MPJ" src="http://www.simbiosys.ca/blog/images/2009-11-30-picture1.jpg" /></p> <p><em>Picture1: Phenol binding to Insulin.Several potential binding pockets are detected for this small ligand.</em></p> <p>1NGP (N1G9 FAB fragment) is a case where the majority of poses are generated far from the native ligand. Picture 2 below shows that most of the poses are located in the big cavity between chains L and H of the crystal structure. Several poses, however, reproduce the x-ray binding mode (in cyan) with close to 1 Å RMSD.</p> <p><img align="middle" alt="1NGP" title="1NGP" src="http://www.simbiosys.ca/blog/images/2009-11-30-picture2.jpg" /></p> <p><em>Picture2: 2-(4-hydroxy-3-nitrophenyl)acetic acid docked into N1G9 FAB fragment. The majority of poses are located in the big cavity between chains L and H.</em></p> <p align="justify" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif"><strong>Conclusion</strong></font><font face="Liberation Serif, Times New Roman, serif"><strong>s:</strong></font></p> <p>The above results clearly demonstrate the viability of eHiTS as a blind docking tool. In all cases the correct binding pocket has been identified in the top 32 solutions, and in most cases good poses under 2 Å and even 1 Å were found at the top of the generated poses. The conformations may be further refined by clipping the receptor for subsequent runs, and by working at higher accuracies. As always in eHiTS, the jobs are extremely easy to setup with a simple command line, and with no required preparation for the receptor or the ligand. This, and the speed of the calculations make eHiTS a high throughput blind docking solution.</p> <p align="justify" style="margin-bottom: 0.08in"><meta http-equiv="CONTENT-TYPE" content="text/html; charset=utf-8" /><title /><meta name="GENERATOR" content="OpenOffice.org 2.4 (Unix)" /><font face="Liberation Serif, Times New Roman, serif"> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } H2 { margin-bottom: 0.08in } H2.western { font-family: "Liberation Sans", "Arial", sans-serif; font-size: 14pt; font-style: italic } H2.cjk { font-family: "DejaVu Sans"; font-size: 14pt; font-style: italic } H2.ctl { font-family: "DejaVu Sans"; font-size: 14pt; font-style: italic } --> </style></font></p> <h2 class="western"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif">Reference:</font></font></h2> <ol><font face="Liberation Serif, Times New Roman, serif"> <font face="Liberation Serif, Times New Roman, serif"> <font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif" /></font> <font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif" /></font></font></font> <font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif" /></font></font></font></font></font></font> <font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"></p> <li>Hetenyi, C. Van der Spoel, D.: ”Blind docking of drug-sized compounds to proteins with up to a thousand residues.”;<br /> 2006 Feb 20;580(5):1447-50. Epub 2006 Jan 31.</li> <li><a target="_blank" title="eHiTS 2009.1 blind docking results in table form" href="http://www.simbiosys.ca/blog/2009-11-30-blind_docking_blog_results_table.html">Blind docking results for eHiTS 2009.1</a>, using the test set of Hetenyi et.al.[1]</li> <p></font></font></font></font></font></font></font></ol> <p><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"> </font></font></font></font></p> <p><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"> </font></font></font></font></p> <p align="left" style="margin-bottom: 0.08in"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"> </font></font></font></font></p> <p><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"> </font><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif"><font face="Liberation Serif, Times New Roman, serif">by Orr Ravitz</font></font></font></font> </font> </font></font> </p> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts in Software products" rel="category tag">Software products</a>, <a href="http://www.simbiosys.com/blog/category/science/" title="View all posts in Science" rel="category tag">Science</a>, <a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts in Technology" rel="category tag">Technology</a>, <a href="http://www.simbiosys.com/blog/category/science/tips-and-hints/" title="View all posts in tips and hints" rel="category tag">tips and hints</a> | <a href="http://www.simbiosys.com/blog/2009/12/01/ehits-2009-as-a-blind-docking-tool/#respond" title="Comment on eHiTS 2009 as a Blind Docking Tool">No Comments »</a></p> </div> <div class="navigation"> <div class="alignleft"></div> <div class="alignright"></div> </div> </div> <div id="sidebar"> <ul> <li> <a href="http://www.simbiosys.com"><img src="images/SimBioSysLogo_name_long.gif" width="200" ></a> </li> <li> <form method="get" id="searchform" action="http://www.simbiosys.com/blog/"> <div><input type="text" value="" name="s" id="s" /> <input type="submit" id="searchsubmit" value="Search" /> </div> </form> </li> <li> <form style="border:1px solid #ccc;padding:3px;text-align:center;" action="http://www.feedburner.com/fb/a/emailverify" method="post" target="popupwindow" onsubmit="window.open('http://www.feedburner.com/fb/a/emailverifySubmit?feedId=1550225', 'popupwindow', 'scrollbars=yes,width=550,height=520');return true"><p>Enter your email address:</p><p><input type="text" style="width:140px" name="email"/></p><input type="hidden" value="http://feeds.feedburner.com/~e?ffid=1550225" name="url"/><input type="hidden" value="SimBioSys Blog" name="title"/><input type="hidden" name="loc" value="en_US"/><input type="submit" value="Subscribe" /><p>Delivered by <a href="http://www.feedburner.com" target="_blank">FeedBurner</a></p></form> </li> <!-- Author information is disabled per default. Uncomment and fill in your details if you want to use it. <li><h2>Author</h2> <p>A little something about you, the author. Nothing lengthy, just an overview.</p> </li> --> <li> <p>You are currently browsing the <a href="http://www.simbiosys.com/blog/">SimBioSys Blog</a> weblog archives for December, 2009.</p> </li> <li class="pagenav"><h2>Pages</h2><ul><li class="page_item"><a href="http://www.simbiosys.com/blog/about/" title="About SimBioSys">About SimBioSys</a></li> </ul></li> <li><h2>Archives</h2> <ul> <li><a href='http://www.simbiosys.com/blog/2013/02/' title='February 2013'>February 2013</a></li> <li><a href='http://www.simbiosys.com/blog/2012/07/' title='July 2012'>July 2012</a></li> <li><a href='http://www.simbiosys.com/blog/2012/05/' title='May 2012'>May 2012</a></li> <li><a href='http://www.simbiosys.com/blog/2012/03/' title='March 2012'>March 2012</a></li> <li><a href='http://www.simbiosys.com/blog/2012/01/' title='January 2012'>January 2012</a></li> <li><a href='http://www.simbiosys.com/blog/2011/12/' title='December 2011'>December 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2011/11/' title='November 2011'>November 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2011/09/' title='September 2011'>September 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2011/08/' title='August 2011'>August 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2011/04/' title='April 2011'>April 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2011/03/' title='March 2011'>March 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2011/01/' title='January 2011'>January 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2010/10/' title='October 2010'>October 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/09/' title='September 2010'>September 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/08/' title='August 2010'>August 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/07/' title='July 2010'>July 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/06/' title='June 2010'>June 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/03/' title='March 2010'>March 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/01/' title='January 2010'>January 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2009/12/' title='December 2009'>December 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/11/' title='November 2009'>November 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/10/' title='October 2009'>October 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/07/' title='July 2009'>July 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/06/' title='June 2009'>June 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/05/' title='May 2009'>May 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/03/' title='March 2009'>March 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/02/' title='February 2009'>February 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/01/' title='January 2009'>January 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2008/12/' title='December 2008'>December 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/11/' title='November 2008'>November 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/10/' title='October 2008'>October 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/09/' title='September 2008'>September 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/08/' title='August 2008'>August 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/07/' title='July 2008'>July 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/06/' title='June 2008'>June 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/05/' title='May 2008'>May 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/04/' title='April 2008'>April 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/03/' title='March 2008'>March 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/02/' title='February 2008'>February 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/01/' title='January 2008'>January 2008</a></li> </ul> </li> <li><h2>Categories</h2> <ul> <li><a href="http://www.simbiosys.com/blog/category/general-discussion/" title="View all posts filed under General Discussion">General Discussion</a> (22) </li> <li><a href="http://www.simbiosys.com/blog/category/news/" title="View all posts filed under News">News</a> (69) </li> <li><a href="http://www.simbiosys.com/blog/category/science/" title="View all posts filed under Science">Science</a> (44) </li> <li><a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts filed under Software products">Software products</a> (41) </li> <li><a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts filed under Technology">Technology</a> (21) </li> <li><a href="http://www.simbiosys.com/blog/category/science/tips-and-hints/" title="Tells us tips and hints on how to best use eHiTS, and other SimBioSys tools, to maximize your ROI (return on invested time, money, energy etc.). It’s a must-read!">tips and hints</a> (5) </li> </ul> </li> </ul> </div> <hr /> <div id="footer"> <!-- If you'd like to support WordPress, having the "powered by" link someone on your blog is the best way, it's our only promotion or advertising. --> <p> SimBioSys Blog is proudly powered by <a href="http://wordpress.org/">WordPress</a> <br /><a href="feed:http://www.simbiosys.com/blog/feed/">Entries (RSS)</a> and <a href="feed:http://www.simbiosys.com/blog/comments/feed/">Comments (RSS)</a>. <!-- 15 queries. 0.100 seconds. --> </p> </div> </div> <!-- Gorgeous design by Michael Heilemann - http://binarybonsai.com/kubrick/ --> </body> </html>